Julie A Johnson

Biography
As a leader and researcher, Johnson is internationally renowned in the fields of pharmacogenomics and genomic medicine with more than 300 peer reviewed publications and nearly $50 million in research funding as principal investigator. She is the first female dean of the University of Florida College of Pharmacy and a distinguished professor in both the colleges of Pharmacy and Medicine. Johnson’s research focuses on cardiovascular pharmacogenomics and genomic medicine implementation. She’s played an important role in the discovery of genetic variants that influence response to cardiovascular drugs, a leader in developing tools for clinical implementation of pharmacogenetics, including warfarin pharmacogenetics dosing algorithms, and more recently has documented the clinical benefits of genotype-guided approaches to drug therapy. In 2015, 2016, 2017 and 2018 she was named a Clarivate Analytics Highly Cited Scientist, indicating she is in the top 1% of the most highly cited scientists in the field globally. Johnson has served on the Nonprescription Drugs Advisory Committee of the FDA, the XNDA Study Section at NIH, and in numerous scientific capacities with NIH’s NHLBI. She has had leadership roles in the American College of Clinical Pharmacy (ACCP), the American Heart Association (AHA), and the American Society of Clinical Pharmacology and Therapeutics (ASCPT). She is an elected fellow of the ACCP, the AHA and the American College of Clinical Pharmacology (ACCP-Pharmacology). Johnson was elected to the National Academy of Medicine and has received the Paul Dawson Biotechnology Research Award, American Association of Colleges of Pharmacy (AACP) (2007), Therapeutic Frontiers Award (2009) and Russell R Miller Award for Contributions to the Literature (2010), both from ACCP, the Southeastern Universities Research Association Distinguished Scientist Award (2015); AACP Volwiler Research Achievement Award (2016), the ACCP-Pharmacology Distinguished Scientist Award (2019), and ACCP Paul Parker Medal (2019), among others. Johnson joined the faculty at the University of Florida in May 1998. Prior to her appointment, she held a faculty position for nine years at the University of Tennessee College of Pharmacy. She received her B.S. in Pharmacy from the Ohio State University and her Pharm D from the University of Texas at Austin and the UT Health Science Center at San Antonio. She completed a post-doctoral fellowship in cardiovascular pharmacology/pharmacokinetics at Ohio State.